MP21-06 LEVERAGING A ROBUST PATIENT-DERIVED XENOGRAFT PLATFORM TO CHARACTERIZE PREDICTORS FOR ENGRAFTMENT AND ONCOLOGIC OUTCOMES IN RENAL CELL CARCINOMA PATIENTS
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.